勤続によるキャリア形成を図る観点から)】 In order to communicate with corporate clients in Japanese, we ask that applicants be able to speak and read basic... Japanese at a basic business level. 【加入保険】各種社会保険完備(加入要件を満たした方) 【受動喫煙対策】 受動喫煙対策あり(屋内禁煙) 【契約期間】内定時までに開示※当社の雇用は正社員です。 応募...
勤続によるキャリア形成を図る観点から)】 In order to communicate with corporate clients in Japanese, we ask that applicants be able to speak and read basic... Japanese at a basic business level. 【加入保険】各種社会保険完備(加入要件を満たした方) 【受動喫煙対策】 受動喫煙対策あり(屋内禁煙) 【契約期間】内定時までに開示※当社の雇用は正社員です。 応募...
未経験可 In order to communicate with corporate clients in Japanese, we ask that applicants be able to speak and read basic... Japanese at a basic business level. 【加入保険】各種社会保険完備(加入要件を満たした方) 【受動喫煙対策】 受動喫煙対策あり(屋内禁煙) 【契約期間】内定時までに開示※当社の雇用は正社員です。 応募...
Tunwal E-Motors IPO: With a face value of ₹2, each share in Tunwal E-Motors' initial public offering (IPO) is priced at ₹59. A minimum of 2000 shares, as well as multiples of those, are up for bid. Continue Reading »
Northern Arc Capital, which filed preliminary IPO papers with SEBI in January, received its observation letter on July 12, according to an update. Continue Reading »
A harsh summer likely aided Crompton’s June quarter results.Crompton took a strategic call to shift Butterfly’s focus from B2B to retail Continue Reading »
Sati Poly Plast IPO: The issue that opened for subscription on July 12, received a strong response as was subscribed 136.65 times by 5:00 PM on day 2. The GMP rose from ₹70 to ₹105 on day 2. The issue will be available for subscription till Tuesday 16 July 2024. Continue Reading »
IREDA's asset quality showed sequential improvement, with gross NPA reducing to 2.19% from 2.36% in March, and net NPA improving to 0.95% from 0.99% in March. Continue Reading »
Deepak Shenoy expects Nifty 50 aggregated EPS to report a high single digit on the back of strong earnings growth from sectors like Financials, Automobiles & FMCG sectors. Continue Reading »
Stock Market Today: Indian Pharma market growth at 6.7% yoy in June softened over April and May. IPCA, Glenmark, Ajanta, Mankind, Sun pharma, Zydus Lifesciences , Procter & Gamble Health Ltd, JB Pharma, Eris Lifesciences were some prominent names that with 7.2-12% yoy growth beat the IPM growth. Continue Reading »